Urioste–Martinez–Frias syndrome

Urioste–Martinez–Frias Syndrome

Urioste–Martinez–Frias syndrome is a rare genetic disorder characterized by a combination of craniofacial anomalies, skeletal abnormalities, and developmental delay. It is named after the researchers who first described the condition. The syndrome is part of a group of disorders that affect the development of multiple body systems.

Clinical Features

Individuals with Urioste–Martinez–Frias syndrome typically present with a distinct set of clinical features, which may include:

• Craniofacial Anomalies: These may include microcephaly, hypertelorism (widely spaced eyes), and a broad nasal bridge.
• Skeletal Abnormalities: Patients may exhibit short stature, scoliosis, and other bone malformations.
• Developmental Delay: Affected individuals often experience delays in reaching developmental milestones, such as walking and talking.
• Other Features: Additional symptoms may include congenital heart defects, genitourinary anomalies, and hearing loss.

Genetics

The genetic basis of Urioste–Martinez–Frias syndrome is not fully understood, but it is believed to follow an autosomal recessive inheritance pattern. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder.

Diagnosis

Diagnosis of Urioste–Martinez–Frias syndrome is primarily based on clinical evaluation and the identification of characteristic features. Genetic testing may be used to confirm the diagnosis and to differentiate it from other similar syndromes.

Management

There is no cure for Urioste–Martinez–Frias syndrome, and treatment is focused on managing symptoms and improving quality of life. This may involve:

• Multidisciplinary Care: Involving specialists such as pediatricians, geneticists, orthopedic surgeons, and speech therapists.
• Supportive Therapies: Including physical therapy, occupational therapy, and speech therapy to address developmental delays and improve functional abilities.
• Surgical Interventions: To correct skeletal deformities or congenital heart defects, if necessary.

Prognosis

The prognosis for individuals with Urioste–Martinez–Frias syndrome varies depending on the severity of symptoms and the presence of associated complications. Early intervention and supportive care can improve outcomes and enhance the quality of life for affected individuals.

Also see

• Genetic disorders
• Craniofacial syndromes
• Developmental delay
• Skeletal dysplasia

NIH genetic and rare disease info

• NIH info on Urioste–Martinez–Frias syndrome

Urioste–Martinez–Frias syndrome is a rare disease.

Urioste–Martinez–Frias syndrome Resources
Latest articles Most recent articles Ongoing trials	Wikipedia